HK1035535A1 - Crystalline forms of osanetant - Google Patents

Crystalline forms of osanetant

Info

Publication number
HK1035535A1
HK1035535A1 HK01106232A HK01106232A HK1035535A1 HK 1035535 A1 HK1035535 A1 HK 1035535A1 HK 01106232 A HK01106232 A HK 01106232A HK 01106232 A HK01106232 A HK 01106232A HK 1035535 A1 HK1035535 A1 HK 1035535A1
Authority
HK
Hong Kong
Prior art keywords
osanetant
crystalline forms
crystalline
forms
Prior art date
Application number
HK01106232A
Other languages
English (en)
Inventor
Alain Alcade
Gilles Anne-Archard
Patrick Grosclaude
Olivier Monnier
Jerome Roche
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of HK1035535A1 publication Critical patent/HK1035535A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK01106232A 1998-08-05 2001-09-04 Crystalline forms of osanetant HK1035535A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9810107A FR2782082B3 (fr) 1998-08-05 1998-08-05 Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
PCT/FR1999/001914 WO2000007987A1 (fr) 1998-08-05 1999-08-03 Formes cristallines du osanetant

Publications (1)

Publication Number Publication Date
HK1035535A1 true HK1035535A1 (en) 2001-11-30

Family

ID=9529458

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01106232A HK1035535A1 (en) 1998-08-05 2001-09-04 Crystalline forms of osanetant

Country Status (32)

Country Link
US (1) US7041679B2 (xx)
EP (1) EP1102747B1 (xx)
JP (1) JP3807938B2 (xx)
KR (1) KR100571944B1 (xx)
CN (1) CN1114592C (xx)
AR (1) AR019953A1 (xx)
AT (1) ATE243197T1 (xx)
AU (1) AU748177B2 (xx)
BR (1) BR9913357A (xx)
CA (1) CA2339007A1 (xx)
CO (1) CO5070576A1 (xx)
DE (1) DE69908951T2 (xx)
DK (1) DK1102747T3 (xx)
DZ (1) DZ3074A1 (xx)
EA (1) EA003205B1 (xx)
EE (1) EE04274B1 (xx)
ES (1) ES2200535T3 (xx)
FR (1) FR2782082B3 (xx)
HK (1) HK1035535A1 (xx)
HU (1) HUP0103134A3 (xx)
IS (1) IS5821A (xx)
MY (1) MY121447A (xx)
NO (1) NO320645B1 (xx)
NZ (1) NZ509561A (xx)
PL (1) PL345999A1 (xx)
PT (1) PT1102747E (xx)
SK (1) SK1742001A3 (xx)
TR (1) TR200100261T2 (xx)
TW (1) TW527354B (xx)
UA (1) UA72890C2 (xx)
WO (1) WO2000007987A1 (xx)
YU (1) YU8601A (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
US7648992B2 (en) * 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
TW202317533A (zh) * 2021-07-02 2023-05-01 美商雅斯治療公司 奧沙奈坦(osanetant)之固體形式

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
WO1998005640A2 (en) * 1996-08-05 1998-02-12 Smithkline Beecham S.P.A. Process for the preparation of 3,3-disubstituted piperidines
US6040316A (en) * 1996-09-16 2000-03-21 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
EA200100096A1 (ru) 2001-08-27
AU748177B2 (en) 2002-05-30
PL345999A1 (en) 2002-01-14
KR100571944B1 (ko) 2006-04-18
NO320645B1 (no) 2006-01-09
JP2002522419A (ja) 2002-07-23
WO2000007987A1 (fr) 2000-02-17
EE200100070A (et) 2002-06-17
EP1102747A1 (fr) 2001-05-30
NO20010553D0 (no) 2001-02-01
NO20010553L (no) 2001-04-05
YU8601A (sh) 2003-07-07
MY121447A (en) 2006-01-28
ES2200535T3 (es) 2004-03-01
PT1102747E (pt) 2003-09-30
EE04274B1 (et) 2004-04-15
TR200100261T2 (tr) 2001-06-21
EP1102747B1 (fr) 2003-06-18
CO5070576A1 (es) 2001-08-28
EA003205B1 (ru) 2003-02-27
DK1102747T3 (da) 2003-09-29
TW527354B (en) 2003-04-11
US20040044215A1 (en) 2004-03-04
AU5168599A (en) 2000-02-28
FR2782082B3 (fr) 2000-09-22
IS5821A (is) 2001-01-23
HUP0103134A2 (en) 2002-06-29
CA2339007A1 (en) 2000-02-17
AR019953A1 (es) 2002-03-27
US7041679B2 (en) 2006-05-09
KR20010072220A (ko) 2001-07-31
CN1314888A (zh) 2001-09-26
FR2782082A1 (fr) 2000-02-11
NZ509561A (en) 2002-10-25
UA72890C2 (en) 2005-05-16
BR9913357A (pt) 2001-05-15
ATE243197T1 (de) 2003-07-15
DE69908951D1 (de) 2003-07-24
HUP0103134A3 (en) 2003-03-28
DE69908951T2 (de) 2004-05-19
DZ3074A1 (fr) 2004-07-20
CN1114592C (zh) 2003-07-16
SK1742001A3 (en) 2001-11-06
JP3807938B2 (ja) 2006-08-09

Similar Documents

Publication Publication Date Title
PL346544A1 (en) Crystalline forms of eto2
IL137616A0 (en) Variants of vegf-a
HK1023125A1 (en) Crystalline form of 4-Ä5-methyl-3-phenylisoxazol-4-ylÜbenzenesulfonamide
TW563457U (en) Structure of novel brush
PL352296A1 (en) Crystalline derivatives of 1-methylocarbapeneme
GB2334731B (en) Spacing of tiles
SG134977A1 (en) Crystalline efavirenz
HK1035535A1 (en) Crystalline forms of osanetant
IL137684A0 (en) Salts of paroxetine
IL140385A0 (en) Salts of paroxetine
IL140766A0 (en) Novel salts of n-tert-butylhydroxylamine
GB9813679D0 (en) Improved structure of toothbrush
PL337612A1 (en) Crystalline form of roxyfiban
HUP9902855A3 (en) Preparation of sterol- and stanol-esters
PL342931A1 (en) Crystalline form of paroxetine
SI1102747T1 (en) Crystalline forms of osanetant
SI1107980T1 (en) CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH
TW475509U (en) Structure of tool set
TW355988U (en) Improved structure for inserting-hook of curtain
PL340294A1 (en) Antipsychoic substituted derivatives of piperidine
TW354479U (en) Improvement of earpick
TW398188U (en) Improved structure of de-hooker
TW400703U (en) Improvement of toothbrush structure
TW351237U (en) Improvement of multi-fucntion stapler
TW398368U (en) Improved structure of wrench

Legal Events

Date Code Title Description
PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070803